HomeBTAI ā¢ NASDAQ
add
BioXcel Therapeutics Inc
Previous close
$1.34
Day range
$1.25 - $1.37
Year range
$1.03 - $12.21
Market cap
48.79M USD
Avg Volume
703.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 582.00K | 182.52% |
Operating expense | 24.66M | -52.01% |
Net income | -26.79M | 49.26% |
Net profit margin | -4.60K | 82.04% |
Earnings per share | -0.87 | 52.72% |
EBITDA | -24.08M | 52.88% |
Effective tax rate | ā | ā |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 74.14M | -55.21% |
Total assets | 82.32M | -54.29% |
Total liabilities | 154.69M | 21.71% |
Total equity | -72.36M | ā |
Shares outstanding | 37.53M | ā |
Price to book | -0.62 | ā |
Return on assets | -77.43% | ā |
Return on capital | -161.41% | ā |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -26.79M | 49.26% |
Cash from operations | -17.71M | 66.18% |
Cash from investing | ā | ā |
Cash from financing | 26.63M | 10.26% |
Net change in cash | 8.92M | 131.63% |
Free cash flow | -9.45M | 73.67% |
About
Founded
2017
Headquarters
Website
Employees
74